In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Racura Oncology Ltd Balance Sheet Statement - Assets

As of 30 Jun 2025, The total current assets of Racura Oncology Ltd (ASX:RAC) was around $14,959,212 which consisted of $13,665,796 of Cash, no Inventory and $29,825 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$13,665,796
Current assets
$14,959,212
Total assets
$17,489,975

The latest balance sheet of Racura Oncology Ltd also showed no Property Plant Equipment and no Good will. Also there were $2,530,763 of Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $17,489,975.

Racura Oncology Ltd Balance Sheet Statement - Liabilities

RAC's latest annual results shows the balance sheet has $457,625 of Accounts Payable. Also there were no Short/Long term debt, no Long term debt, no Other Current liabilities and $1,453,932 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$457,625
Current liabilities
$1,453,932
Total liabilities
$1,478,533

As per the 30 Jun 2025's annual report of Racura Oncology Ltd, the total liabilities were $1,478,533.

RAC Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Racura Oncology Ltd showed the total stock holder equity was $16,011,442 which consisted of $68,490,033 of Common stocks, $-62,205,416 of Retained earnings and no Other stock holder equity.

RAC Balance Sheet Statement History

Following table shows the history of balance sheet for Racura Oncology Ltd (RAC).

30 Jun 2025 30 Jun 2024 30 Jun 2023 30 Jun 2022 30 Jun 2021
Cash 13,665,796 17,188,827 21,520,368 33,540,790 -
Net Receivables 29,825 105,693 1,704,099 62,465 -
Inventory - - - - -
Total Current Assets 14,959,212 17,416,614 23,544,781 34,150,399 -
Property Plant Equipment - - - - -
Good Will - - - - -
Intangible Assets 2,530,763 2,811,959 3,093,155 3,374,350 -
Other Assets - - - - -
Deferred Long Term Asset Charges - - - - -
Total Assets 17,489,975 20,228,573 26,637,936 37,524,749 -
Accounts Payable 457,625 1,199,041 638,514 833,822 -
Short/Long Term Debt - - - - -
Other Current Liabilities - - - - 1
Long Term Debt - - - - -
Other Liabilities - - - - -
Total Current Liabilities 1,453,932 1,868,169 1,151,795 1,417,340 -
Total Liabilities 1,478,533 1,916,425 1,151,795 1,417,340 -
Common Stock 68,490,033 66,947,929 61,709,155 62,016,810 -
Retained Earnings -62,205,416 -57,418,158 -43,598,822 -33,675,397 -
Treasury Stock - - - - -
Other Stockholder Equity - - - - -
Total Stockholder Equity 16,011,442 18,312,148 25,486,141 36,107,409 -
Net Tangible Assets 13,480,679 15,500,189 22,392,986 32,733,059 -

Racura Oncology Ltd (ASX:RAC) Balance Sheet Statement FAQ

1. How much Cash Racura Oncology Ltd has on their balance sheet?

As of 30 Jun 2025, Racura Oncology Ltd (ASX:RAC) has $13,665,796 of Cash.

2. What's the long term debt of Racura Oncology Ltd?

As per the latest Balance sheet of Racura Oncology Ltd (ASX:RAC), it has no Long term debt.

3. How much share holder equity does Racura Oncology Ltd has?

The Racura Oncology Ltd (ASX:RAC)'s balance sheet shows that it has $16,011,442 of Total stock holder equity.